Motilin vs Linaclotide

Head-to-head comparison of Motilin (Motilin) and Linaclotide (Linaclotide) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyMotilinLinaclotide
CategoryGastrointestinalGastrointestinal
Full NameMotilinLinaclotide
Molecular Weight~2.7 kDa1526.8 Da
Half-Life~20 minActive locally; negligible systemic half-life
Amino Acids2214
Typical DoseNo standard approved dose; experimental use only72-290 mcg once daily
RouteIV|SCOral
Purity≥98%≥98%
Studies Count811200
Research StatusEndogenousClinical

Motilin Benefits

  • migrating motor complex support
  • gastric emptying
  • small-bowel clearance

Linaclotide Benefits

  • improves-bowel-movements
  • reduces-abdominal-pain
  • increases-intestinal-secretion
  • supports-transit

Motilin Dosing

0.1–1 mg (experimental)|IV/SC

Linaclotide Dosing

72 mcg PO daily|145 mcg PO daily|290 mcg PO daily

Motilin Side Effects

  • cramping
  • nausea

Linaclotide Side Effects

  • diarrhea
  • abdominal-pain
  • bloating

Research Overview

Motilin

Motilin is a 22-amino-acid peptide released from the upper small intestine and is one of the classic physiologic prokinetic signals. It is a real peptide target for GI motility research, though not commonly used as a standard drug.

Linaclotide

Linaclotide has extensive clinical evidence for chronic idiopathic constipation and IBS-C, with consistent effects on stool frequency and abdominal symptom relief. Its mechanism is local GC-C activation in the gut with minimal systemic exposure.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Motilin stacks with:

MLNmotilin

Linaclotide stacks with:

dietary-fiberhydrationmagnesium
motilityprokineticgastric-emptyingibs-cconstipationgc-c-agonistintestinal-secretion